Biopharmaceuticals Contract Manufacturing Market Analysis/Research Report 2022-2030: Merger & Acquisitions in CMO industry, Trading of CMOs at Strong EV/EBITDA Multiples, Current Trends –

DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, by Service (Upstream, Downstream, Fill/Finish), by Product (Biologics), by Region and Segment Forecasts, 2022-2030” report has been added to’s offering. The global biopharmaceuticals contract manufacturing market size is expected to reach USD 27.3 billion by 2030, growing at a CAGR … [Read more…]

n-Lorem Launches its Patient Empowerment Program to Support Nano-rare Patients and Their Families

Program includes new podcast series of informative interviews with thought leaders and lessons from basic science through the continuum of drug development. SAN DIEGO–(BUSINESS WIRE)–n-Lorem, a nonprofit foundation, launches its patient advocacy initiative referred to as the ‘Patient Empowerment Program,’ with the release of its new podcast series. Through this program, n-Lorem hopes to foster … [Read more…]

Osivax Provides Clinical Development Update on Lead Influenza Vaccine Candidate OVX836

Excellent safety continues to be observed in ongoing Phase 2a dose optimization study (OVX836-003) Phase 2a dose optimization study extended to elderly population cohort (OVX836-003) Additional Phase 2a trial combining OVX836 with conventional quadrivalent influenza vaccine (QIV) initiated with first participants enrolled in Australia (OVX836-004) LYON, France–(BUSINESS WIRE)–Osivax, a biopharmaceutical company developing vaccines to provide … [Read more…]

Global Blood Plasma Derivatives Market Report 2022: A $40.5 Billion Market in 2021 – Industry Trends, Share, Size, Growth, Opportunity and Forecasts to 2027 –

DUBLIN–(BUSINESS WIRE)–The “Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to’s offering. The global blood plasma derivatives market reached a value of US$ 40.5 billion in 2021. Looking forward, the market is projected to reach a value of US$ 59.8 billion by 2027, exhibiting … [Read more…]

Ellipses Pharma and SunRock Biopharma Enter Into a Licensing Agreement for a First-in-class Bifunctional HER3:TRAIL Fusion Protein

Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours LONDON & SANTIAGO DE COMPOSTELA, Spain–(BUSINESS WIRE)–SunRock Biopharma S.L. (“SunRock”), a biopharmaceutical company that is developing a portfolio of innovative bispecific antibodies to treat incurable cancer, and Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development … [Read more…]

FEELM Wins 4 Red Dot Awards for Product Design 2022 for Innovative Atomization Products

SHENZHEN, China–(BUSINESS WIRE)–#award–FEELM, the flagship atomization tech brand belonging to SMOORE, today announced that it has been awarded Red Dot Awards for Product Design 2022 for 4 innovative atomization products, including the world’s thinnest ceramic coil vape pod solution FEELM Air, eco-friendly non-nicotine disposable e-cigarette, and anti-dust mouthpiece hygienic e-cigarette. By virtue of creative product … [Read more…]

NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment

NuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management. LONDON–(BUSINESS WIRE)–#asthma–NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung function … [Read more…]

Cutera, Inc. Announces Pricing of Offering of $200 Million and Concurrent Private Placement of $10 Million of Convertible Senior Notes

BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced the pricing of $210 million aggregate principal amount of 2.25% convertible senior notes due 2028 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of … [Read more…]

First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of Oncology

Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with late-stage cancer PALO ALTO, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, today announced … [Read more…]

Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries

Pfizer will provide all its current and future patent-protected medicines and vaccines available in the U.S. or EU on a not-for-profit basis to 45 lower-income countries. Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to commit to join the Accord. Health officials in these countries will help identify and resolve hurdles beyond … [Read more…]